ProKidney Corp. Class A Ordinary Shares
$1.91
Market Cap
$399.05M
Shares Outstanding
208.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 12, 2022
Round Lot
100
Locale
US
Day Open
$1.79
Day High
$1.98
Day Low
$1.79
Volume
9.45M
VWAP
$1.91
Prev Close
$1.80
Transactions
--
Acc. Volume
--
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
ProKidney Corp. Class A Ordinary Shares (PROK) closed the 2026-09-18 session at $1.91, up 6.11% versus the previous close (+0.11). The stock opened at $1.79 and traded between $1.79 and $1.98 during that session. Session trading volume was 9.5M shares. The volume-weighted average price (VWAP) is $1.91.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
ProKidney Corp. Class A Ordinary Shares has a market capitalization of $399.1 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. PROK is listed on the XNAS exchange. The company employs approximately 231 people. ProKidney Corp. Class A Ordinary Shares is headquartered in WINSTON-SALEM, NC. The recorded listing date is 2022-07-12.
On this page you can find market PROK stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.